Shen T - Search Results

1

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.

Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D. Ping Z, et al. Among authors: shen t, shen d. Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019. Oncotarget. 2016. PMID: 27811364 Free PMC article.

2

A microscopic landscape of the invasive breast cancer genome.

Ping Z, Xia Y, Shen T, Parekh V, Siegal GP, Eltoum IE, He J, Chen D, Deng M, Xi R, Shen D. Ping Z, et al. Among authors: shen t, shen d. Sci Rep. 2016 Jun 10;6:27545. doi: 10.1038/srep27545. Sci Rep. 2016. PMID: 27283966 Free PMC article.

3

Clinicopathologic factors associated with de novo metastatic breast cancer.

Shen T, Siegal GP, Wei S. Shen T, et al. Pathol Res Pract. 2016 Dec;212(12):1167-1173. doi: 10.1016/j.prp.2016.09.007. Epub 2016 Sep 22. Pathol Res Pract. 2016. PMID: 27692496

4

Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.

Shen T, Brandwein-Gensler M, Hameed O, Siegal GP, Wei S. Shen T, et al. Hum Pathol. 2015 Nov;46(11):1776-84. doi: 10.1016/j.humpath.2015.07.019. Epub 2015 Aug 4. Hum Pathol. 2015. PMID: 26363528

5

Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis.

Ren Z, Li Y, Shen T, Hameed O, Siegal GP, Wei S. Ren Z, et al. Among authors: shen t. Pathol Res Pract. 2016 Jan;212(1):24-30. doi: 10.1016/j.prp.2015.11.003. Epub 2015 Nov 10. Pathol Res Pract. 2016. PMID: 26616114

6

Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.

Shen T, Zhang K, Siegal GP, Wei S. Shen T, et al. Am J Clin Pathol. 2016 Nov 1;146(5):603-610. doi: 10.1093/ajcp/aqw183. Am J Clin Pathol. 2016. PMID: 27780797

7

The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.

Wang K, Shen T, Siegal GP, Wei S. Wang K, et al. Among authors: shen t. Hum Pathol. 2017 Nov;69:110-117. doi: 10.1016/j.humpath.2017.09.012. Epub 2017 Oct 6. Hum Pathol. 2017. PMID: 28993275

8

Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.

Shen T, Gao C, Zhang K, Siegal GP, Wei S. Shen T, et al. Hum Pathol. 2017 Dec;70:70-76. doi: 10.1016/j.humpath.2017.10.002. Epub 2017 Oct 13. Hum Pathol. 2017. PMID: 29031733

9

Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.

Chen S, Fritchie K, Wei S, Ali N, Curless K, Shen T, Brini AT, Latif F, Sumathi V, Siegal GP, Cheng L. Chen S, et al. Among authors: shen t. Hum Pathol. 2017 Jul;65:239-246. doi: 10.1016/j.humpath.2017.05.015. Epub 2017 May 25. Hum Pathol. 2017. PMID: 28552826 Free article.

10

Corrigendum to "Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone" [Hum Pathol 2017;65:239-46].

Chen S, Fritchie K, Wei S, Ali N, Curless K, Shen T, Brini AT, Latif F, Sumathi V, Siegal GP, Cheng L. Chen S, et al. Among authors: shen t. Hum Pathol. 2017 Nov;69:143. doi: 10.1016/j.humpath.2017.10.001. Epub 2017 Nov 13. Hum Pathol. 2017. PMID: 29146074 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,969 results

Search Page

Filters